AI assistant
Sending…
Alligator Bioscience — Major Shareholding Notification 2022
Mar 1, 2022
3138_iss_2022-03-01_0c3abc83-db7c-4838-a951-e820b27c2b33.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer

Issuer Alligator Bioscience AB
Holder
Allegro Investment Funt, L.P.
Instrument
| Instrument | Common Shares | |
|---|---|---|
| Before the transaction | ||
| Shares | 48,883,052 | |
| Voting rights | 48,883,052 | |
| Transaction | ||
| Date | 24/02/2022 | |
| Limit for number of shares 25 % | ||
| Limit for number of votes | 25 % | |
| After the transaction | ||
| Quantity |
Shares 55,643,092 Directly held voting rights 55,643,092 Indirectly held voting rights 0 Percentage
| Directly held shares | 25.22525 % |
|---|---|
| Directly held voting rights 25.22525 % | |
| Indirectly held voting rights 0 % |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|
| Shares | 25.22525 % | 55,643,092 |
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
||
| - Physically settled - Cash settled |
||
| Total | 25.22525 % | 55,643,092 |
| Group total holdings Voting rights 55,643,092 Percentage of voting rights 25.22525 |
||
| Published 01/03/2022 10:28 |

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from Alligator Bioscience
AGM Information
2026
May 6
AGM Information
2026
May 6
Interim / Quarterly Report
2026
May 5
Interim / Quarterly Report
2026
May 5
Share Issue/Capital Change
2026
Mar 31
Share Issue/Capital Change
2026
Mar 31
Proxy Solicitation & Information Statement
2026
Mar 30
Proxy Solicitation & Information Statement
2026
Mar 30
Board/Management Information
2026
Mar 27
Board/Management Information
2026
Mar 27